Literature DB >> 14744952

Renal disease, homocysteine, and cardiovascular complications.

Killian Robinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14744952     DOI： 10.1161/01.CIR.0000114133.99074.96

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  8 in total

1.  Hyperhomocysteinaemia as a potential marker of early renal function decline in middle-aged Asian people without chronic kidney disease.

Authors:  Young Jin Tak; Dong Wook Jeong; Yun Jin Kim; Sang Yeoup Lee; Jeong Gyu Lee; Sang Heon Song; Kwang Soo Cha; Yang Ho Kang
Journal:  Int Urol Nephrol       Date:  2016-01-02       Impact factor: 2.370

Review 2.  Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator.

Authors:  Utpal Sen; Sathnur B Pushpakumar; Matthew A Amin; Suresh C Tyagi
Journal:  Nitric Oxide       Date:  2014-06-22       Impact factor: 4.427

Review 3.  Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension.

Authors:  Gregory J Weber; Sathnur Pushpakumar; Suresh C Tyagi; Utpal Sen
Journal:  Pharmacol Res       Date:  2016-09-04       Impact factor: 7.658

4.  Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly.

Authors:  Linlin Wang; Hongtian Li; Yuan Zhou; Lei Jin; Jianmeng Liu
Journal:  Eur J Nutr       Date:  2014-06-11       Impact factor: 5.614

5.  Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects.

Authors:  Mohamed El-Sammak; Mona Kandil; Safaa El-Hifni; Randa Hosni; Mahmoud Ragab
Journal:  Int J Med Sci       Date:  2004-10-12       Impact factor: 3.738

Review 6.  Low Vitamin B12 and Lipid Metabolism: Evidence from Pre-Clinical and Clinical Studies.

Authors:  Joseph Boachie; Antonysunil Adaikalakoteswari; Jinous Samavat; Ponnusamy Saravanan
Journal:  Nutrients       Date:  2020-06-29       Impact factor: 5.717

Review 7.  Homocysteine-Lowering Interventions in Chronic Kidney Disease.

Authors:  Shirinsadat Badri; Sahar Vahdat; Shiva Seirafian; Morteza Pourfarzam; Tahereh Gholipur-Shahraki; Sara Ataei
Journal:  J Res Pharm Pract       Date:  2021-12-25

Review 8.  Folic Acid and Homocysteine in Chronic Kidney Disease and Cardiovascular Disease Progression: Which Comes First?

Authors:  Giuseppe Cianciolo; Antonio De Pascalis; Luca Di Lullo; Claudio Ronco; Chiara Zannini; Gaetano La Manna
Journal:  Cardiorenal Med       Date:  2017-06-21       Impact factor: 2.041
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.